Circulating miRNAs can serve as potential diagnostic biomarkers in chronic myelogenous leukemia patients
Introduction: Chronic Myelogenous Leukemia (CML) is a myeloproliferative disorder described as a malignant blood disorder by accounts for 15–20% of all adult leukemia. MicroRNAs (miRNAs) play an important role in post-transcriptional regulation of gene expressions. Expression level of tumor suppress...
Main Authors: | Farid Keramati, Arefeh Jafarian, Adele Soltani, Ehsan Javandoost, Mojtaba Mollaei, Parviz Fallah |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048921000248 |
Similar Items
-
Human Telomerase Reverse Transcriptase (hTERT) expression in patients with Chronic Myelogenous Leukemia at defferent phases of the disease
by: A Amini, et al.
Published: (2008-09-01) -
Human Telomerase Reverse Transcriptase (hTERT) Expression in Patients with Chronic Myelogenous Leukemia at Different Phases of the Disease
by: K Alimoghadam, et al.
Published: (2008-08-01) -
Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013-01-01) -
Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01) -
Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)